Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia gravis in rhesus monkeys
Abstract Autoantibodies against ion channels are the cause of numerous neurologic autoimmune disorders. Frequently, such pathogenic autoantibodies have a restricted epitope-specificity. In such cases, competing antibody formats devoid of pathogenic effector functions (blocker antibodies) have the po...
Guardado en:
Autores principales: | Mario Losen, Aran F. Labrijn, Vivianne H. van Kranen-Mastenbroek, Maarten L. Janmaat, Krista G. Haanstra, Frank J. Beurskens, Tom Vink, Margreet Jonker, Bert A. ‘t Hart, Marina Mané-Damas, Peter C. Molenaar, Pilar Martinez-Martinez, Eline van der Esch, Janine Schuurman, Marc H. de Baets, Paul W. H. I. Parren |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/24f5b6bf021946909f7c67a223ec548b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Frontalis sling procedure for ocular myasthenia gravis
por: Isogai N, et al.
Publicado: (2012) -
Optimal Design for Compliant Mechanism Flexure Hinges: Bridge-Type
por: Chia-Nan Wang, et al.
Publicado: (2021) -
Coenzyme Q at the Hinge of Health and Metabolic Diseases
por: Juan Diego Hernández-Camacho, et al.
Publicado: (2021) -
Profound olfactory dysfunction in myasthenia gravis.
por: Fidias E Leon-Sarmiento, et al.
Publicado: (2012) -
Fetal Surveillance in Pregnancies with Myasthenia Gravis
por: Brîndușa Ana Cimpoca-Raptis, et al.
Publicado: (2021)